8-K ·Filed Aug 19, 2026

FOCL

EDAP TMS SA
BEARISH
Impact 6/10
Horizonimmediate Processed1mo ago SEC0001104659-26-098487
8-K context-dependent: Items 8.01
Actionable Insight ▼ Bearish

The full exercise of the over-allotment option adds ~15% more shares on top of the initial 29% dilutive offering, for total dilution of ~44% from pre-offering levels. Monitor for further share price pressure as the additional 1.26M ADSs hit the market on August 19. The $5.6M net proceeds provide a modest cash buffer but do not offset the substantial dilution to existing holders.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+20d
FOCL ▼ -1.83% at T+20d
SHORT call ✓ call won +1.83% · α vs SPY -0.12% · entry $4.36 → $4.28
Next anchor: T+60d in 6w
Latest observation: T+29 -0.02% FF3 residual α
Entry anchored
Aug 19, 2026
via day open
T+1d
-3.21%
call +3.21% · α +2.37%
$4.22
settled 6w ago
T+5d
+1.15%
call -1.15% · α -1.53%
$4.41
settled 5w ago
T+20d
-1.83%
call +1.83% · α -0.12%
$4.28
settled 16d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

EDAP TMS SA reports that underwriters fully exercised their option to purchase an additional 1,263,750 ADSs in the company's public offering at $4.75 per ADS, expected to close August 19, 2026, generating approximately $5.6 million in net proceeds. This represents incremental dilution of ~15% on top of the initial 8.425M ADS offering, increasing total shares sold to ~9.7M ADSs for gross proceeds of ~$46M.

Key Facts

  • Underwriters fully exercised the option to purchase an additional 1,263,750 ADSs at $4.75 per ADS.
  • The additional issuance is expected to close on August 19, 2026.
  • Expected net proceeds from the option exercise are approximately $5.6 million.
  • Total offering: 8,425,000 ADSs initially plus 1,263,750 additional = ~9.7M ADSs.
  • Offering price was $4.75 per ADS.
  • Market cap is ~$160M; the total offering represents ~29% dilution at the offering price.

Financial Impact

Incremental dilution of ~15% from the option exercise, adding ~$5.6M net to the company's cash balance. Total offering dilution of ~29% relative to pre-offering share count.

dilutioncash

Risk Factors

  • Significant dilution to existing shareholders from the combined ~9.7M ADS offering.
  • Potential near-term selling pressure as additional shares are issued and distributed.
  • No operational or financial update provided to justify the capital raise.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
73% bullish (11 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-098487
Document: tm2623508d1_ex5-1.htm0001104659-26-098487
Document: 0001104659-26-098487-index-headers.html0001104659-26-098487
Document: 0001104659-26-098487-index.html0001104659-26-098487
Document: 0001104659-26-098487.txt0001104659-26-098487
6 reports for FOCL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for FOCL — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
8-K
BEARISH ★ 6/10
$4.36 $4.28▲ +1.83%▼ −0.12%$4.20 (+3.67%)
Aug 14, 2026
7w ago
8-K
BEARISH ★ 6/10
$4.76 $4.11▲ +13.66%▲ +11.66%$4.20 (+11.76%)
Aug 13, 2026
7w ago
8-K
MIXED ★ 6/10
$4.76 $4.11▼ −13.66%▼ −11.66%$4.20 (−11.76%)
Aug 12, 2026
7w ago
Press Release
MIXED ★ 6/10
$4.75 $4.16▼ −12.42%▼ −10.52%$4.20 (−11.58%)
Aug 11, 2026
7w ago
8-K
BULLISH ★ 7/10
$4.75 $4.16▼ −12.42%▼ −10.52%$4.20 (−11.58%)
Jul 30, 2026
9w ago
Press Release
NEUTRAL ★ 4/10
$6.12 $4.31▼ −29.58%▼ −32.56%$4.20 (−31.37%)
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (35h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access